Isaac Barchas's most recent trade in Immunome Inc was a trade of 371,949 Common Stock done at an average price of $21.7 . Disclosure was reported to the exchange on Dec. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunome Inc | Isaac Barchas | Director | Sale of securities on an exchange or to another person at price $ 21.72 per share. | 22 Dec 2025 | 371,949 | 2,042,432 | - | 21.7 | 8,078,732 | Common Stock |
| Immunome Inc | Isaac Barchas | Director | Sale of securities on an exchange or to another person at price $ 22.34 per share. | 22 Dec 2025 | 11,251 | 2,031,181 | - | 22.3 | 251,347 | Common Stock |
| Immunome Inc | Isaac Barchas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2025 | 18,864 | 18,864 | - | - | Director Stock Option (right to buy) | |
| Immunome Inc | Isaac Barchas | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 11,333 | 11,333 | - | - | Stock option (right to buy) |